Kiadis Pharma NV (LTS:0RBP) Short-Term Capital Lease Obligation : €0.94 Mil (As of Dec. 2020)

View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Short-Term Capital Lease Obligation?

Kiadis Pharma NV's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2020 was €0.94 Mil.

Kiadis Pharma NV's quarterly Short-Term Capital Lease Obligation declined from Dec. 2019 (€1.24 Mil) to Jun. 2020 (€1.06 Mil) and declined from Jun. 2020 (€1.06 Mil) to Dec. 2020 (€0.94 Mil).

Kiadis Pharma NV's annual Short-Term Capital Lease Obligation increased from Dec. 2018 (€1.03 Mil) to Dec. 2019 (€1.24 Mil) but then declined from Dec. 2019 (€1.24 Mil) to Dec. 2020 (€0.94 Mil).

Kiadis Pharma NV Short-Term Capital Lease Obligation Historical Data

The historical data trend for Kiadis Pharma NV's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Short-Term Capital Lease Obligation Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.03

1.24

0.94

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial											1.03	1.58	1.24	1.06	0.94

Kiadis Pharma NV Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Kiadis Pharma NV Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (LTS:0RBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (LTS:0RBP) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (LTS:0RBP) Headlines

No Headlines